RXRX
Recursion Pharmaceuticals, Inc.NASDAQHealthcare$3.15+1.29%ClosedMarket Cap: $1.41B
As of 2026-04-07
Insider Statistics (Q2 2026)
Purchases
2
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 02 | Li Dean Y | director | Sell | 3,268 | $0.00 | 1,244,177 |
| Thu Apr 02 | Dar Zavain | director | Sell | 4,902 | $0.00 | 147,231 |
| Wed Mar 25 | Gibson Christopher | director | Sell | 40,000 | $3.25 | 906,556 |
| Wed Mar 25 | Gibson Christopher | director | Sell | 40,000 | $0.00 | 4,483,334 |
| Wed Mar 18 | Taylor Ben R | officer: Chief Financial Officer | Sell | 7,075 | $3.42 | 1,188,274 |
| Wed Mar 18 | Taylor Ben R | officer: Chief Financial Officer | Sell | 7,956 | $3.39 | 1,180,318 |
| Wed Mar 11 | Khan Najat | director, officer: CEO and President | Sell | 28,298 | $3.35 | 2,262,085 |
| Wed Mar 11 | Gibson Christopher | director | Sell | 20,000 | $0.00 | 906,556 |
| Wed Mar 11 | Gibson Christopher | director | Sell | 20,000 | $0.00 | 4,523,334 |
| Wed Mar 04 | Borgeson Blake | director | Sell | 170,000 | $3.46 | 6,259,863 |
| Thu Feb 19 | Hallett David | officer: Chief Scientific Officer | Sell | 11,908 | $3.49 | 1,097,151 |
| Thu Feb 19 | Gibson Christopher | director | Sell | 40,000 | $0.00 | 4,543,334 |